The Coca-Cola Company (NYSE:KO) shares moved down -0.37% in last trading session and ended the day at $45.50. KO Gross Margin is 60.50% and its has a return on assets of 8.00%. The Coca-Cola Company (NYSE:KO) quarterly performance is 7.89%.
The Coca-Cola Company (NYSE:KO) will release first quarter 2016 financial results on Wednesday, April 20, 2016, before the stock market opens. The Company will host an investor conference call at 9 a.m. EDT on April 20, 2016.
Wal-Mart Stores Inc. (NYSE:WMT) ended the last trading day at $67.87. Company weekly volatility is calculated as 1.88% and price to cash ratio as 24.96. Wal-Mart Stores Inc. (NYSE:WMT) showed a weekly performance of -0.32%.
Wal-Mart Stores, Inc. (NYSE: WMT) announced that the company’s 2016 Annual Shareholders’ Meeting will be held on Friday, June 3, 2016, at 8:00 a.m. CDT in the Bud Walton Arena at the University of Arkansas in Fayetteville, Ark.
On 22 March, Evercore Partners Inc. (NYSE:EVR) shares moved down -0.55% and was closed at $52.08. EVR EPS growth in last 5 year was 14.90%. Evercore Partners Inc. (NYSE:EVR) year to date (YTD) performance is -3.01%.
Evercore Trust Company, a subsidiary of Evercore (NYSE:EVR), announced that Lori E. Bostrom has joined the business as a Managing Director based in New York, further expanding the legal and regulatory expertise of the team.
Banco Santander-Chile (NYSE:BSAC) shares advanced 0.20% in last trading session and ended the day at $19.63. BSAC has a return on assets of 1.30%. Banco Santander-Chile (NYSE:BSAC) quarterly performance is 12.36%.
At the regular meeting of the Board of Directors of Banco Santander – Chile (NYSE:BSAC), held March 16, 2016, it was agreed upon to summons an ordinary shareholders meeting on April 26, 2016 with the objective among other matters, to propose for approval to shareholders a dividend of Ch$1.42919851 per share, corresponding to 60% of net income attributable to shareholders in 2015. In addition, the remaining 40% of net income attributable to shareholders in 2015 will be destined to increase reserves.
Cellular Biomedicine Group Inc. (NASDAQ:CBMG) caters to the Healthcare space. Its weekly performance is 8.58%. On the last day of trading company shares ended up at $16.84.
On 14 March, Cellular Biomedicine Group Inc. (NASDAQ:CBMG) reported Full-year 2015 revenue was $2.5 million compared to $0.6 million in 2014. All revenue for the year ended December 31, 2015 was derived from TCR technology services. G&A Expenses: Full-year 2015 general and administrative expenses were $13.1 million compared $7.9 million in 2014. Increased expenses in 2015 were associated with increased corporate activities related to the management and the development of the Company’s biomedicine business.
Leave a Reply